SCHEDULE 13G/AAccepted Aug 14, 5:22 PM ET
Spyre Therapeutics, Inc. SCHEDULE 13G/A
Accepted (ET)
5:22 PM
Aug 14, 2026
Filed
Aug 14, 2026
Documents
1
Size
11.1 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.